Genomics and Blockchain Converge to Understand and Overcome Disease

Source: ARK Disrupt Issue 105: December 24th, 2017 https://ark-invest.com/research/ark-disrupt-issue-105 Follow @msamyARK on Twitter

Led by former executives from DNA sequencing powerhouse, Illumina ILMN, Luna DNA is harnessing the power of blockchain technology to incentivize individuals to contribute their DNA and medical history to a distributed database. Hosted on Ethereum’s blockchain, Luna DNA rewards data contributors with Luna Coins and partial ownership of the genomic database.

In general, blockchain technology creates a low-friction way to incentivize data-sharing while allowing the decentralized ownership of data, offering both privacy and trust. Specifically, in the case of Luna, once it collects a critical mass of anonymous genomic data, pharmaceutical companies will be able to query similarities and differences among patient cohorts and surface new therapeutic leads, paying for the information with Luna Coins, as shown below.

Luna DNA is planning a token sale totaling $40-50 million sometime during the first quarter of 2018. ARK will be paying close attention to this important convergence between health care and technology.

image depicting routing of information and Luna Coins

2018-07-21T13:19:39-04:00 December 24th, 2017|